Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF
Condition(s):Heart Failure With Preserved Ejection FractionLast Updated:March 15, 2024Active, not recruiting